{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:34Z","timestamp":1791644254840,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2010-0657"],"award-info":[{"award-number":["PICT-2010-0657"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2014-0854"],"award-info":[{"award-number":["PICT-2014-0854"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020130100788BA"],"award-info":[{"award-number":["20020130100788BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PUE-0017CO-2016"],"award-info":[{"award-number":["PUE-0017CO-2016"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bbadis.2019.165658","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T21:00:36Z","timestamp":1577998836000},"page":"165658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control"],"prefix":"10.1016","volume":"1866","author":[{"given":"Augusto E.","family":"Bivona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s S\u00e1nchez","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n N.","family":"Trinitario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio L.","family":"Malchiodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.165658_bb0005","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.bbadis.2019.165658_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.bbadis.2019.165658_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002865","article-title":"2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/CMR.00005-11","article-title":"Trypanosoma cruzi and Chagas\u2019 disease in the United States","volume":"24","author":"Bern","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbadis.2019.165658_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003540","article-title":"Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis","volume":"9","author":"Requena-M\u00e9ndez","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0030","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.vaccine.2016.03.074","article-title":"Status of vaccine research and development of vaccines for Chagas disease","volume":"34","author":"Beaumier","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0035","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.bbadis.2019.165658_bb0040","doi-asserted-by":"crossref","first-page":"489758","DOI":"10.1155\/2015\/489758","article-title":"Experimental vaccines against Chagas disease: a journey through history","volume":"2015","author":"Rodr\u00edguez-Morales","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbadis.2019.165658_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/14760584.2015.989989","article-title":"Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease","volume":"14","author":"S\u00e1nchez-Vald\u00e9z","year":"2015","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.bbadis.2019.165658_bb0050","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.2174\/092986709788802971","article-title":"Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target","volume":"16","author":"Duschak","year":"2009","journal-title":"A Review., Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2019.165658_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0264-410X(03)00541-3","article-title":"Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes","volume":"22","author":"Frank","year":"2003","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/652872","article-title":"Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection","volume":"202","author":"Cazorla","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0065","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1046\/j.1365-2958.1999.01440.x","article-title":"Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele","volume":"32","author":"Allaoui","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0248-4900(94)90011-6","article-title":"Trypanosoma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S-transferases","volume":"80","author":"Sch\u00f6neck","year":"1994","journal-title":"Biol. Cell."},{"key":"10.1016\/j.bbadis.2019.165658_bb0075","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.4049\/jimmunol.168.12.6366","article-title":"The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via toll-like receptor 2, and confers protection against lethal infection","volume":"168","author":"Ouaissi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0080","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/IAI.02190-14","article-title":"Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar typhimurium induces protection against a trypanosoma cruzi lethal challenge","volume":"82","author":"Matos","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0085","doi-asserted-by":"crossref","first-page":"47078","DOI":"10.1074\/jbc.M106017200","article-title":"Trypanosoma cruzi Prolyl Oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes","volume":"276","author":"Grellier","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.bbadis.2019.165658_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj3250129","article-title":"A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV","volume":"325","author":"Santana","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2019.165658_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20041049","article-title":"Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells","volume":"388","author":"Bastos","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2019.165658_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006384","article-title":"Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine","volume":"12","author":"Bivona","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0110","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/IAI.72.11.6245-6254.2004","article-title":"Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening","volume":"72","author":"Bhatia","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0115","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00144-08","article-title":"Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice","volume":"15","author":"Bhatia","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004828","article-title":"A two-component DNA-prime\/protein-boost vaccination strategy for eliciting long-term, protective T cell immunity against Trypanosoma cruzi","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2019.165658_bb0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/IAI.01163-07","article-title":"Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi","volume":"76","author":"Cazorla","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0130","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2008.02.011","article-title":"Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model","volume":"26","author":"Cazorla","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/jiu480","article-title":"Oral multicomponent DNA vaccine delivered by attenuated Salmonella elicited immunoprotection against American trypanosomiasis","volume":"211","author":"Cazorla","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0140","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.vaccine.2016.05.011","article-title":"A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection","volume":"34","author":"Matos","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005300","article-title":"Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi","volume":"11","author":"Matos","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0150","series-title":"Engineered Trivalent Immunogen Adjuvanted With a STING Agonist Confers Protection Against Trypanosoma cruzi Infection","author":"Sanchez Alberti","year":"2017"},{"key":"10.1016\/j.bbadis.2019.165658_bb0155","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2019.165658_bb0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2019.165658_bb0165","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature."},{"key":"10.1016\/j.bbadis.2019.165658_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2249.1990.tb05409.x","article-title":"Isolation of a Trypanosoma cruzi antigen by affinity chromatography with a monoclonal antibody. Preliminary evaluation of its possible applications in serological tests","volume":"82","author":"Carbonetto","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0175","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1128\/IAI.70.9.5065-5074.2002","article-title":"Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice","volume":"70","author":"Schnapp","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41541-019-0107-7","article-title":"A prophylactic \u03b1-Gal-based glycovaccine effectively protects against murine acute Chagas disease","volume":"4","author":"Portillo","year":"2019","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.bbadis.2019.165658_bb0185","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1128\/IAI.73.9.6017-6025.2005","article-title":"CD8+-T-cell-dependent control of trypanosoma cruzi Infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2","volume":"73","author":"Araujo","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0190","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.179.10.6889","article-title":"Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming","volume":"179","author":"Hoft","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0195","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/IAI.00278-09","article-title":"Intranasal vaccinations with the trans-sialidase antigen plus CpG adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges","volume":"78","author":"Giddings","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0200","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4049\/jimmunol.158.7.3311","article-title":"IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi","volume":"158","author":"Hunter","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/JLB.3A0318-111RR","article-title":"IL-10 participates in the expansion and functional activation of CD8 + T cells during acute infection with Trypanosoma cruzi","volume":"105","author":"Pino-Mart\u00ednez","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0210","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165658_bb0215","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.4049\/jimmunol.149.12.4048","article-title":"IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10","volume":"149","author":"te Velde","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0220","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2007.06.004","article-title":"Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes","volume":"68","author":"Lingnau","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.gene.6364135","article-title":"IL-10 stimulatory effects on human NK cells explored by gene profile analysis","volume":"5","author":"Mocellin","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.vaccine.2018.11.041","article-title":"TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice","volume":"37","author":"Hegazy-Hassan","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030382","article-title":"NKT cell stimulation with \u03b1-Galactosylceramide results in a block of Th17 differentiation after intranasal immunization in mice","volume":"7","author":"Zygmunt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165658_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002658","article-title":"IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils","volume":"8","author":"Tosello Boari","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2019.165658_bb0245","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.2569","article-title":"Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR\u03b3t and Ahr that leads to IL-17 production by activated B cells","volume":"14","author":"Bermejo","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005902","article-title":"Th17 cells are more protective than Th1 cells against the intracellular parasite Trypanosoma cruzi","volume":"12","author":"Cai","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2019.165658_bb0255","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1462-5822.2012.01831.x","article-title":"Trypanosoma cruzi trans -sialidase as a multifunctional enzyme in Chagas\u2019 disease","volume":"14","author":"dC-Rubin","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0260","doi-asserted-by":"crossref","first-page":"e1005559","DOI":"10.1371\/journal.ppat.1005559","article-title":"Sialic acid glycobiology unveils Trypanosoma cruzi trypomastigote membrane physiology","volume":"12","author":"Lantos","year":"2016","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.bbadis.2019.165658_bb0265","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1073\/pnas.87.7.2846","article-title":"Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns","volume":"87","author":"Reyes","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2019.165658_bb0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0166-6851(92)90038-L","article-title":"Mapping of a B-cell epitope present in the neuraminidase of Trypanosoma cruzi","volume":"52","author":"Prioli","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0275","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/iai.62.8.3441-3446.1994","article-title":"Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trans-sialidase that inhibit its activity","volume":"62","author":"Leguizam\u00f3n","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0280","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.vaccine.2015.01.044","article-title":"Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease","volume":"33","author":"Bontempi","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0285","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/21645515.2018.1520581","article-title":"Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice","volume":"15","author":"de la Cruz","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bbadis.2019.165658_bb0290","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4049\/jimmunol.1000432","article-title":"CD8 + T cells specific for Immunodominant Trans -Sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance","volume":"185","author":"Rosenberg","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00241-16","article-title":"Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant Trans -Sialidase-Specific CD8+ T Cells","author":"Rosenberg","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0300","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1089\/hum.2004.15.878","article-title":"Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the Amastigote surface Protein-2 and trans-Sialidase","volume":"15","author":"Vasconcelos","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2019.165658_bb0305","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1016\/j.vaccine.2010.08.104","article-title":"Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells","volume":"28","author":"Limon-Flores","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0310","first-page":"513","article-title":"Membrane-bound cysteine proteinase isoforms in different developmental stages of Trypanosoma cruzi","volume":"44","author":"Parussini","year":"1998","journal-title":"Cell. Mol. Biol. (Noisy-Le-Grand)."},{"key":"10.1016\/j.bbadis.2019.165658_bb0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0166-6851(92)90219-A","article-title":"The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes","volume":"50","author":"Campetella","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0320","doi-asserted-by":"crossref","first-page":"e1002699","DOI":"10.1371\/journal.ppat.1002699","article-title":"Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine","volume":"8","author":"Vasconcelos","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbadis.2019.165658_bb0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.0818-9641.2002.01136.x","article-title":"A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain","volume":"81","author":"Vasconcelos","year":"2003","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0330","doi-asserted-by":"crossref","first-page":"e22011","DOI":"10.1371\/journal.pone.0022011","article-title":"Subdominant\/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite","volume":"6","author":"Dominguez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165658_bb0335","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.160.4.1817","article-title":"Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL","volume":"160","author":"Low","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0340","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.0901178","article-title":"Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection","volume":"183","author":"Padilla","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0345","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/S0074-02762009000900038","article-title":"Protective immunity against Trypanosoma cruzi","volume":"104","author":"Parodi","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bbadis.2019.165658_bb0350","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0264-410X(97)00277-6","article-title":"Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice","volume":"16","author":"Costa","year":"1998","journal-title":"Vaccine."},{"key":"10.1016\/j.bbadis.2019.165658_bb0355","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1371\/journal.pntd.0000983","article-title":"Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi","volume":"5","author":"Eickhoff","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0360","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/978-1-4939-3389-1_44","article-title":"Attenuated Salmonella sp. as a DNA delivery system for Trypanosoma cruzi antigens","author":"Bivona","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0370","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3389\/fmicb.2018.02100","article-title":"Genetic engineering of Lactococcus lactis co-producing antigen and the mucosal adjuvant 3\u2032 5\u2032- cyclic di adenosine monophosphate (c-di-AMP) as a design strategy to develop a mucosal vaccine prototype","volume":"9","author":"Quintana","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0375","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/hum.2006.17.898","article-title":"Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding Amastigote surface Protein-2 and Trans- Sialidase","volume":"17","author":"Machado","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2019.165658_bb0380","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/IAI.01190-10","article-title":"Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi","volume":"79","author":"Rigato","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0385","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00281-015-0481-9","article-title":"CD8+ T cells in Trypanosoma cruzi infection","volume":"37","author":"Tarleton","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0390","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1590\/0074-02760140440","article-title":"Reaching for the holy grail: insights from infection\/cure models on the prospects for vaccines for Trypanosoma cruzi infection","volume":"110","author":"Bustamante","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bbadis.2019.165658_bb0395","doi-asserted-by":"crossref","first-page":"e61795","DOI":"10.1371\/journal.pone.0061795","article-title":"Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection","volume":"8","author":"Barbosa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165658_bb0400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1743-422X-8-127","article-title":"Biological and immunological characterization of recombinant yellow fever 17D viruses expressing a Trypanosoma cruzi Amastigote surface Protein-2 CD8+ T cell epitope at two distinct regions of the genome","volume":"8","author":"Nogueira","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.bbadis.2019.165658_bb0405","doi-asserted-by":"crossref","first-page":"e59347","DOI":"10.1371\/journal.pone.0059347","article-title":"Recombinant Yellow Fever Viruses Elicit CD8+ T Cell Responses and Protective Immunity against Trypanosoma cruzi","volume":"8","author":"Nogueira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165658_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006809","article-title":"The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission","volume":"12","author":"Bartsch","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007413","article-title":"A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection","volume":"13","author":"Barry","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","article-title":"Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice","volume":"50","author":"Sanchez-Burgos","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0425","doi-asserted-by":"crossref","first-page":"e1004594","DOI":"10.1371\/journal.ppat.1004594","article-title":"5 Adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy","volume":"11","author":"Pereira","year":"2015","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.bbadis.2019.165658_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130562","article-title":"Therapeutic efficacy of a subunit vaccine in controlling chronic Trypanosoma cruzi infection and Chagas disease is enhanced by glutathione peroxidase over-expression","volume":"10","author":"Gupta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165658_bb0435","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/21645515.2015.1078044","article-title":"Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection","volume":"12","author":"Cerny","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.bbadis.2019.165658_bb0440","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1242\/jcs.114.21.3933","article-title":"Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi","volume":"114","author":"Monteiro","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2019.165658_bb0445","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1242\/jcs.01677","article-title":"Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells","volume":"118","author":"Santos","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2019.165658_bb0450","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and Posaconazole in eliminating parasites in asymptomatic T. Cruzi carriers","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2019.165658_bb0455","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00876-17","article-title":"Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease","volume":"86","author":"Jones","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbadis.2019.165658_bb0460","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/21645515.2015.1119346","article-title":"A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB\/c mouse model of Chagas disease","volume":"12","author":"Barry","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bbadis.2019.165658_bb0465","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)61422-7","article-title":"Socioeconomic aspects of neglected tropical diseases","volume":"375","author":"Conteh","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.bbadis.2019.165658_bb0470","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0475","doi-asserted-by":"crossref","first-page":"e916","DOI":"10.1371\/journal.pntd.0000916","article-title":"The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America","volume":"4","author":"Lee","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbadis.2019.165658_bb0480","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4161\/hv.20966","article-title":"Modeling the economic value of a Chagas\u2019 disease therapeutic vaccine","volume":"8","author":"Lee","year":"2012","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919303898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919303898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:56:39Z","timestamp":1760417799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919303898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0925443919303898"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165658","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165658"}}